Form4insider filings, from the source

Insider holders · CIK 0001689813

Biohaven Pharmaceutical Holding Co Ltd. · BHVN

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
John W ChildsDirector—2,719,4382,719,438May 9, 2017 · 4:47 pm EDTForm 4
Gregory BaileyDirector2,475,101—2,475,101Feb 2, 2018 · 6:17 pm ESTForm 4
Albert ChaDirector—2,049,5452,049,545Mar 15, 2018 · 6:20 pm EDTForm 4
Declan DooganDirector373,9131,026,0021,399,915Mar 1, 2019 · 5:59 pm ESTForm 4
Vlad CoricChief Executive Officer—525,000525,000Feb 14, 2019 · 4:32 pm ESTForm 5
PORTAGE BIOTECH INC.relationship not stated54,494—54,494Jan 25, 2018 · 4:13 pm ESTForm 4/A
Charles ConwayChief Scientific Officer4,000—4,000May 11, 2017 · 5:00 pm EDTForm 4
John TiltonChief Commercial Officer01,6141,614Jan 14, 2019 · 5:50 pm ESTForm 4
Robert BermanChief Medical Officer—5050Feb 14, 2019 · 4:28 pm ESTForm 5
James EngelhartChief Financial Officer0—0May 30, 2018 · 6:02 pm EDTForm 4
Kimberly GentileVP of Operations0—0Jun 19, 2018 · 4:43 pm EDTForm 4
Robert RepellaDirector0—0Sep 11, 2018 · 4:17 pm EDTForm 3
Eric AguiarDirector—00Feb 6, 2019 · 6:21 pm ESTForm 4
Julia P GregoryDirector0—0Feb 25, 2019 · 4:40 pm ESTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.